Meyer Handelman Co. Acquires Shares of 16,932 Cencora, Inc. $COR

Meyer Handelman Co. bought a new position in shares of Cencora, Inc. (NYSE:COR) in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 16,932 shares of the company’s stock, valued at approximately $5,319,000.

A number of other institutional investors also recently modified their holdings of COR. Kemnay Advisory Services Inc. bought a new stake in Cencora in the 4th quarter valued at about $25,000. Oakworth Capital Inc. bought a new position in shares of Cencora during the fourth quarter worth approximately $26,000. Elyxium Wealth LLC bought a new position in shares of Cencora during the fourth quarter worth approximately $27,000. Archer Investment Corp increased its holdings in shares of Cencora by 134.3% during the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after purchasing an additional 47 shares during the period. Finally, Motiv8 Investments LLC acquired a new stake in shares of Cencora in the fourth quarter valued at approximately $29,000. Institutional investors own 97.52% of the company’s stock.

Insider Activity

In other Cencora news, Director Lauren M. Tyler purchased 550 shares of the firm’s stock in a transaction dated Monday, June 22nd. The shares were bought at an average price of $270.23 per share, for a total transaction of $148,626.50. Following the purchase, the director owned 4,359 shares in the company, valued at approximately $1,177,932.57. This trade represents a 14.44% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.38% of the company’s stock.

Cencora Stock Performance

Shares of Cencora stock opened at $287.55 on Friday. The company has a 50 day moving average of $281.44 and a 200-day moving average of $322.43. Cencora, Inc. has a 1-year low of $244.82 and a 1-year high of $377.54. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. The company has a market cap of $55.95 billion, a PE ratio of 22.05, a price-to-earnings-growth ratio of 1.53 and a beta of 0.59.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The firm had revenue of $78.36 billion during the quarter, compared to the consensus estimate of $81.09 billion. During the same period last year, the business earned $4.42 earnings per share. The business’s revenue was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, equities research analysts forecast that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.

Cencora declared that its board has initiated a share buyback plan on Thursday, May 21st that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the company to reacquire up to 3.9% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s leadership believes its stock is undervalued.

Cencora Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend was Friday, May 15th. Cencora’s dividend payout ratio (DPR) is currently 18.40%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on COR shares. Wells Fargo & Company cut their price target on Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a research note on Monday, May 11th. Leerink Partners restated an “outperform” rating on shares of Cencora in a research note on Tuesday, March 17th. William Blair initiated coverage on Cencora in a report on Tuesday, April 28th. They issued a “market perform” rating for the company. Weiss Ratings downgraded Cencora from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, May 22nd. Finally, Barclays reduced their target price on Cencora from $425.00 to $350.00 and set an “overweight” rating on the stock in a report on Wednesday, June 10th. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $367.75.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.